MRI-guided abciximab for ischemic stroke

Completed

Phase N/A Results

Summary of Purpose

To assess whether abciximab treatment within 3 to 24 hours of stroke results in early neurologic improvement and lessens ischemic lesion growth on DWI.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 September 2005.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • NIH - National Institute of Neurologic Disorders and Stroke

Trial Design

Single-center, open-label, exploratory trial.

Contacts

Not available